BIONANO GENOMICS, INC. (BNGO)
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionanos Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionanos Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical